Implant maker Shoulder Innovations' Q3 revenue beats on volume and price gains; lifts FY outlook
SI•Shoulder Innovations reported Q3 revenue of $16.19 million, up 38% year over year and above the $15.44 million consensus estimate, and raised its 2026 revenue outlook to $68 million-$70 million from $67 million-$69 million.
1. Revenue and outlook
Shoulder Innovations said Q3 revenue rose 38% year over year to $16.19 million, beating the $15.44 million analyst estimate. Growth reflected higher implant system sales to new and existing customers and an increase in average selling price. The company raised its 2026 revenue outlook to $68 million-$70 million from $67 million-$69 million.
2. Loss and product plans
Q3 net loss narrowed to $7.05 million, and gross margin rose on higher average selling prices and cost-reduction programs. The company plans to submit its InSet Neo robotic platform to the FDA in 2027; increased research and development spending was tied to new product development.
